COVID-19: CMS Approves $34Bn For DME Suppliers, Providers Via Accelerated, Advance Pay Programs
The US Medicare agency on 7 April said it delivered $34bn to suppliers of durable medical equipment and other providers fighting COVID-19 via an accelerated payment program.
You may also be interested in...
An advanced payment loan program supported by the CMS for durable medical equipment suppliers and health care providers during the COVID-19 pandemic was suspended by the agency on 26 April.
On this week’s podcast we talk about outgoing US FDA chief Stephen Hahn and the role he wants to play beyond 20 January, as an ex-commissioner. We also discuss the US enforcement landscape around COVID-19-related products and how it’s still taking shape.
The US Medicare agency issued on 12 January its final MCIT rule allowing instant reimbursement for FDA breakthrough devices – unless the incoming Biden administration blocks it.